tiludronic acid has been researched along with Gait Disorders, Animal in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Allen, K; Denoix, JM; Mitchell, RD; Parkin, T; Tischmacher, A; Wilford, S | 1 |
Gillett, AN; McNulty, MA; Mitchell, CF; Richbourg, HA | 1 |
Payton, ME; Schoonover, MJ; Sippel, KM; Whitfield, CT; Young, JM | 1 |
Holbrook, TC; Payton, ME; Schoonover, MJ; Sippel, KM; Whitfield, CT | 1 |
Gough, MR; Smith, RK; Thibaud, D | 1 |
Denoix, JM; Riccio, B; Thibaud, D | 1 |
4 trial(s) available for tiludronic acid and Gait Disorders, Animal
Article | Year |
---|---|
Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial.
Topics: Animals; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling; Clodronic Acid; Diphosphonates; Horse Diseases; Horses; Lameness, Animal; Osteogenesis; Pilot Projects | 2018 |
Quantitative assessment of intravenous regional limb perfusion of tiludronate as an adjunctive treatment for lameness caused by navicular syndrome in horses.
Topics: Administration, Intravenous; Animals; Bone Density Conservation Agents; Diphosphonates; Female; Foot Diseases; Forelimb; Gait; Horse Diseases; Horses; Lameness, Animal; Male; Random Allocation; Syndrome; Tarsal Bones | 2018 |
Tiludronate infusion in the treatment of bone spavin: a double blind placebo-controlled trial.
Topics: Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Hindlimb; Horse Diseases; Horses; Lameness, Animal; Male; Osteoarthritis | 2010 |
Tiludronate as a new therapeutic agent in the treatment of navicular disease: a double-blind placebo-controlled clinical trial.
Topics: Animals; Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Foot Diseases; Hoof and Claw; Horse Diseases; Horses; Injections, Intravenous; Lameness, Animal; Male; Osteitis; Treatment Outcome; Video Recording | 2003 |
2 other study(ies) available for tiludronic acid and Gait Disorders, Animal
Article | Year |
---|---|
Retrospective Analysis of the Use of Tiludronate in Equine Practice: Safety on 1804 Horses, Efficacy on 343 Horses.
Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Horse Diseases; Horses; Lameness, Animal; Retrospective Studies | 2022 |
Quantitative assessment of two methods of tiludronate administration for the treatment of lameness caused by navicular syndrome in horses.
Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Forelimb; Horse Diseases; Horses; Injections, Intravenous; Lameness, Animal | 2016 |